22122992|t|Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.
22122992|a|AIM: To investigate quality of life (QOL) and the effect of memantine treatment in patients with Lewy body dementias. METHODS: A secondary analysis of a randomized controlled study in 70 patients with Parkinson's disease dementia (PDD) or dementia with Lewy bodies (DLB) over 24 weeks using caregiver-rated QOL-Alzheimer's disease (AD) in domains according to the WHO's classification of health. RESULTS: Baseline QOL shows lower ratings for body functions over environmental factors in DLB/PDD. Treatment with memantine significantly improves life as a whole compared to placebo and improves total QOL, body function and structure. CONCLUSION: This study shows that memantine improves QOL in Lewy body dementias. We also demonstrate important QOL patterns which can be used in clinical practice.
22122992	34	43	memantine	Chemical	MESH:D008559
22122992	47	72	dementia with lewy bodies	Disease	MESH:D020961
22122992	77	105	Parkinson's disease dementia	Disease	MESH:D010300
22122992	167	176	memantine	Chemical	MESH:D008559
22122992	190	198	patients	Species	9606
22122992	204	223	Lewy body dementias	Disease	MESH:D020961
22122992	294	302	patients	Species	9606
22122992	308	336	Parkinson's disease dementia	Disease	MESH:D010300
22122992	338	341	PDD	Disease	MESH:D010300
22122992	346	371	dementia with Lewy bodies	Disease	MESH:D020961
22122992	373	376	DLB	Disease	MESH:D020961
22122992	418	437	Alzheimer's disease	Disease	MESH:D000544
22122992	439	441	AD	Disease	MESH:D000544
22122992	594	597	DLB	Disease	MESH:D020961
22122992	598	601	PDD	Disease	MESH:D010300
22122992	618	627	memantine	Chemical	MESH:D008559
22122992	774	783	memantine	Chemical	MESH:D008559
22122992	800	819	Lewy body dementias	Disease	MESH:D020961
22122992	Negative_Correlation	MESH:D008559	MESH:D010300
22122992	Negative_Correlation	MESH:D008559	MESH:D020961

